Adhezion Biomedical Receives FDA Marketing Clearance For SurgiSeal™ Topical Skin Adhesive New Topical Skin Adhesive Is Cleared For U.S. Launch

Adhezion Biomedical LLC, a medical device manufacturer, announced that the FDA has provided marketing clearance for its SurgiSeal (2-octyl cyanoacrylate) topical skin adhesive. SurgiSeal is the first and only 2-octyl cyanoacrylate that does not require an activator. It is indicated for use in surgical and emergency applications.
Continue Read…

This entry was posted in Medical News. Bookmark the permalink.

Leave a Reply